TrademarkDir
ESTERASE SENSITIVE MOTIF
DEAD

Serial Number

79211487

Owner

Macrophage Pharma Limited

Attorney

Bryce J. Maynard

Filing Date

May 9, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ESTERASE SENSITIVE MOTIF Trademark

Serial Number: 79211487

ESTERASE SENSITIVE MOTIF is a trademark filed by Macrophage Pharma Limited on May 9, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Macrophage Pharma Limited (3 trademarks)

St. Stephens House, Arthur Road
Windsor, Berkshire SL41RU , GB

Entity Type: 16

Trademark Details

Filing Date

May 9, 2017

Registration Date

Not Registered

Goods & Services

Chemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposes, namely, for use in oncology, immunotherapy, immuno-oncology and in treating metabolic disease; pharmaceutical preparations for treating cancers; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating metabolic disease

Pharmaceutical research and development services; scientific research services; information, advisory and consultancy services relating to the aforesaid

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 12, 2020 FINT
FINAL DISPOSITION NOTICE SENT TO IB
May 22, 2020 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 22, 2020 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 25, 2019 NREP
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 23, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 22, 2019 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 28, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 12, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 12, 2018 OPNR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Oct 23, 2018 GNS1
SUBSEQUENT FINAL EMAILED
Oct 23, 2018 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Oct 23, 2018 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 17, 2018 ERFR
REFUSAL PROCESSED BY IB
May 12, 2018 RFNT
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 16, 2018 GNFN
FINAL REFUSAL E-MAILED
Mar 16, 2018 GNFR
FINAL REFUSAL WRITTEN
Mar 16, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2018 TROA
REFUSAL PROCESSED BY IB
Sep 1, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 16, 2017 RFCS
REFUSAL PROCESSED BY MPU
Aug 16, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 15, 2017 RFCR
NON-FINAL ACTION WRITTEN
Aug 14, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 5, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 12, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 6, 2017 REPR

Related Trademarks

More from this Owner

ESTERASE SENSITIVE MOTIF

ESTERASE SENSITIVE MOTIF

ESTERASE SENSITIVE MOTIF

ESTERASE SENSITIVE MOTIF